This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Institut Pasteur, National Institute for Agricultural Research, National Institute of Health and Medical Research. Active years: 1998-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Paris, FR (1998 - 2000)
- Vanves, FR (2014)
Company Filing History:



Years Active: 1998-2014
Title: The Innovations of Jean-Marc Reyrat
Introduction
Jean-Marc Reyrat is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of infectious diseases. With a total of 3 patents to his name, Reyrat's work has had a meaningful impact on healthcare.
Latest Patents
One of his latest patents focuses on the diagnosis and treatment of diseases resulting from infections by specific subspecies. This invention involves the use of an antigen selected from a synthetic peptide and a lipopeptide, which are designed for the in vitro detection or quantification of specific anti-antibodies in biological samples. Another patent details a method for selecting allelic exchange mutants, which includes a process for replacing a nucleotide sequence in the genome of a mycobacterium strain.
Career Highlights
Throughout his career, Jean-Marc Reyrat has worked with prestigious institutions such as the Institut Pasteur and the National Institute of Health and Medical Research. His research has contributed to advancements in understanding infectious diseases and developing new diagnostic methods.
Collaborations
Reyrat has collaborated with esteemed colleagues, including Vladimir Pelicic and Brigitte Gicquel. These partnerships have further enhanced the quality and impact of his research.
Conclusion
Jean-Marc Reyrat's innovative work in the field of medical research exemplifies the importance of collaboration and dedication to advancing healthcare solutions. His contributions continue to influence the diagnosis and treatment of infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile